Swedish Cancer Institute Research

Seattle, Washington 98104

We've found

1 trials

at this facility

A Trial of TTI-622 in Patients With Advanced Relapsed or Refractory Lymphoma or Myeloma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Seattle, WA

Use our guide to learn which trials are right for you!